Clinical Trial Update: Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer

View source ↗

Summary

A clinical trial evaluating whether preoperative HbA1c levels affect pathologic features and oncological outcomes in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Seoul National University Hospital | Conditions: Prostate Neoplasm, Pathology | Status: UNKNOWN